Description
The Firm seeks to advance the state of the art in aptamer drug development through the development of novel chemistries of non-natural or modified natural nucleotides and synthesis and purification methods for a large DNA-encoded aptamer li…
Amendment chain · 4 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $137,000 at start, $527,000 after amendment #5 (+$390,000).
- #02023-07-10$137,000
- #12023-10-17$247,000+$110,000
- #32024-03-25$527,000+$280,000
- #52024-09-13$527,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2023-07-10(start date) | $137,000 | — | The Firm seeks to advance the state of the art in aptamer drug development through the development of novel ch… |
| #1 amendment | 2023-10-17 | $247,000 | +$110,000 | The Firm seeks to advance the state of the art in aptamer drug development through the development of novel ch… |
| #3 amendment | 2024-03-25 | $527,000 | +$280,000 | The Firm seeks to advance the state of the art in aptamer drug development through the development of novel ch… |
| #5 amendment | 2024-09-13 | $527,000 | +$0 | The Firm seeks to advance the state of the art in aptamer drug development through the development of novel ch… |
Related records · 11
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 742964521)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2025-2026-Q4-1039317 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program | $357,087 | FY2026 |
| 172-2024-2025-Q4-1025518 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $71,500 | FY2025 |
| 172-2024-2025-Q3-1023902 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Youth Employment Program | $30,000 | FY2025 |
| 172-2024-2025-Q3-1022902 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $63,000 | FY2025 |
| 271-2021-2022-Q4-00124 | Health Canada | Santé Canada · Canadian Health Systems and Programs | $940,000 | FY2022 |
| 172-2020-2021-Q2-955723 | National Research Council Canada | Conseil national de recherches Canada · Innovative Solutions Canada | $266,500 | FY2021 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2023-2024-Q2-1008172 · retrieved 2026-11-13.